Bcr–Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemia

References

• Gluckman E, Rocha V. Cord blood transplantation: state of the art. Haematologica. 2009;94:451–4.
   PubMed Web of Science ®Google Scholar
• Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, . Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–85.
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, . Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA. 1989;86:3828–32.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, . Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989; 321:1174–8.
   PubMed Web of Science ®Google Scholar
• Ooi J. Cord blood transplantation in adults. Bone Marrow Transplant. 2009;44:661–6.
   PubMed Web of Science ®Google Scholar
• Kurtzberg J, Cairo MS, Fraser JK, Baxter-Lowe L, Cohen G, Carter SL, . Results of the cord blood transplantation (COBLT) study unrelated donor banking program. Transfusion. 2005;45:842–55.
   PubMed Web of Science ®Google Scholar
• Rubinstein P. Why cord blood? Hum Immunol. 2006;67: 398–404.
   PubMed Web of Science ®Google Scholar
• Cohen Y, Nagler A. Umbilical cord blood transplantation: how, when and for whom? Blood Rev. 2004;18:167–79.
   PubMed Web of Science ®Google Scholar
• Querol S, Gomez SG, Pagliuca A, Torrabadella M, Madrigal JA. Quality rather than quantity: the cord blood bank dilemma. Bone Marrow Transplant. 2010;45:970–8.
   PubMed Web of Science ®Google Scholar
• Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood. 1997;90:4665–78.
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, . Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–77.
   PubMed Web of Science ®Google Scholar
• Albano MS, Taylor P, Pass RF, Scaradavou A, Ciubotariu R, Carrier C, . Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening. Blood. 2006;108:4275–82.
   PubMed Web of Science ®Google Scholar
• Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, . Donor screening for hepatitis B virus infection in a cell and tissue bank. Transpl Infect Dis. 2008;10:391–5.
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood. 1993;81:1679–90.
   PubMed Web of Science ®Google Scholar
• Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant. 2002;8:257–60.
   PubMed Web of Science ®Google Scholar
• Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, . Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res. 1998;18:4705–8.
   PubMed Web of Science ®Google Scholar
• McCullough J, McKenna D, Kadidlo D, Maurer D, Noreen HJ, French K, . Mislabeled units of umbilical cord blood detected by a quality assurance program at the transplantation center. Blood. 2009;114:1684–8.
   PubMed Web of Science ®Google Scholar
• Thyagarajan B, Berger M, Sumstad D, McKenna DH Jr. Loss of integrity of umbilical cord blood unit freezing bags: description and consequences. Transfusion. 2008;48:1138–42.
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci USA. 2003;100:645–50.
   PubMed Web of Science ®Google Scholar
• Hayakawa J, Joyal EG, Gildner JF, Washington KN, Phang OA, Uchida N, . 5% Dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO. Transfusion. 2010;50:2158–66.
   PubMed Web of Science ®Google Scholar
• Ketheesan N, Whiteman C, Malczewski AB, Hirst RG, La Brooy JT. Effect of cryopreservation on the immunogenicity of umbilical cord blood cells. Transfus Apher Sci. 2004; 30:47–54.
   PubMed Web of Science ®Google Scholar
• Ademokun JA, Chapman C, Dunn J, Lander D, Mair K, Proctor SJ, . Umbilical cord blood collection and separation for haematopoietic progenitor cell banking. Bone Marrow Transplant. 1997;19:1023–8.
   PubMed Web of Science ®Google Scholar
• Armitage S, Fehily D, Dickinson A, Chapman C, Navarrete C, Contreras M. Cord blood banking: volume reduction of cord blood units using a semi-automated closed system. Bone Marrow Transplant. 1999;23:505–9.
   PubMed Web of Science ®Google Scholar
• Newton I, Charbord P, Schaal JP, Herve P. Toward cord blood banking: density-separation and cryopreservation of cord blood progenitors. Exp Hematol. 1993;21:671–4.
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, . Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995;92: 10119–22.
   PubMed Web of Science ®Google Scholar
• Sousa T, de Sousa ME, Godinho MI, Mendes C, Carvalhais A, Barbosa IL. Umbilical cord blood processing: volume reduction and recovery of CD34 + cells. Bone Marrow Transplant. 1997;19:311–3.
   PubMed Web of Science ®Google Scholar
• Zingsem J, Strasser E, Weisbach V, Zimmermann R, Ringwald J, Goecke T, . Cord blood processing with an automated and functionally closed system. Transfusion. 2003;43: 806–13.
   PubMed Web of Science ®Google Scholar
• Brocklebank AM, Sparrow RL. Enumeration of CD34 + cells in cord blood: a variation on a single-platform flow cytometric method based on the ISHAGE gating strategy. Cytometry. 2001;46:254–61.
   PubMedGoogle Scholar
• Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34 + cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry. 1998;34:61–70.
   PubMedGoogle Scholar
• Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34 + cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213–26.
   PubMedGoogle Scholar
• Jan RH, Wen SH, Shyr MH, Chiang BL. Impact of maternal and neonatal factors on CD34 + cell count, total nucleated cells, and volume of cord blood. Pediatr Transplant. 2008; 12:868–73.
   PubMed Web of Science ®Google Scholar
• Manegold G, Meyer-Monard S, Tichelli A, Pauli D, Holzgreve W, Troeger C. Cesarean section due to fetal distress increases the number of stem cells in umbilical cord blood. Transfusion. 2008;48:871–6.
   PubMed Web of Science ®Google Scholar
• McGuckin CP, Basford C, Hanger K, Habibollah S, Forraz N. Cord blood revelations: the importance of being a first born girl, big, on time and to a young mother! Early Hum Dev. 2007;83:733–41.
   PubMed Web of Science ®Google Scholar
• Surbek DV, Holzgreve W, Steinmann C, Hahn S, Gratwohl A, Wodnar-Filipowicz A, . Preterm birth and the availability of cord blood for HPC transplantation. Transfusion. 2000;40:817–20.
   PubMed Web of Science ®Google Scholar
• Papassavas AC, Gioka V, Chatzistamatiou T, Kokkinos T, Anagnostakis I, Gecka G, . A strategy of splitting individual high volume cord blood units into two half subunits prior to processing increases the recovery of cells and facilitates ex vivo expansion of the infused haematopoietic progenitor cells in adults. Int J Lab Hematol. 2008;30:124–32.
   PubMed Web of Science ®Google Scholar
• Sahar E, Latt SA. Enhancement of banding patterns in human metaphase chromosomes by energy transfer. Proc Natl Acad Sci USA 1978;75:5650–5654.
   PubMed Web of Science ®Google Scholar
• Gabert J, Beillard E, van der Velden V, . Standardization and quality control studies of “real-time” quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia--a Europe Against Cancer program. Leukemia 2003;17:2318–2357.
   PubMed Web of Science ®Google Scholar
• Willems R, Van Bockstaele DR, Lardon F, . Decrease in nucleoside diphosphate kinase (NDPK/nm23) expression during hematopoietic maturation. J Biol Chem 1998;273:13663–13668.
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Okabe-Kado J, Sakashita A, . Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia. Blood 1996;88:3555–3561.
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Okabe-Kado J, Wakimoto N, . Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies. Blood 1998;91:1845–1851.
   PubMed Web of Science ®Google Scholar
• Okabe-Kado J, Kasukabe T, Honma Y. Expression of cell surface NM23 proteins of human leukemia cell lines of various cellular lineage and differentiation stages. Leuk Res 2002;26:569–576.
   PubMed Web of Science ®Google Scholar
• Okabe-Kado J. Serum nm23-H1 protein as a prognostic factor in hematological malignancies. Leuk Lymphoma 2002;43:859–867.
   PubMed Web of Science ®Google Scholar
• Okabe-Kado J, Kasukabe T, Honma Y, . Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells. Cancer Sci 2009;100:1885–1894.
   PubMed Web of Science ®Google Scholar
• Lilly AJ, Khanim FL, Hayden RE, . Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone. Cancer Res 2011;71:1177–1186.
   PubMed Web of Science ®Google Scholar
• Anzinger J, Malmquist NA, Gould J, . Secretion of a nucleoside diphosphate kinase (Nm23-H2) by cells from human breast, colon, pancreas and lung tumors. Proc West Pharmacol Soc 2001;44:61–63.
   PubMedGoogle Scholar
• Okabe-Kado J, Kasukabe T, Honma Y, . Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase. Biochem Biophys Res Commun 1992;182:987–994.
   PubMed Web of Science ®Google Scholar
• Ly C, Arechiga AF, Melo JV, . Bcr–Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin. Cancer Res 2003;63:5716–5722.
   PubMed Web of Science ®Google Scholar
• Dreyfuss G, Kim VN, Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 2002;3:195–205.
   PubMed Web of Science ®Google Scholar
• Keene JD. Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome. Proc Natl Acad Sci USA 2001;98:7018–7024.
   PubMed Web of Science ®Google Scholar
• Keene JD, Tenenbaum SA. Eukaryotic mRNPs may represent posttranscriptional operons. Mol Cell 2002;9:1161–1167.
   PubMed Web of Science ®Google Scholar
• Perrotti D, Turturro F, Neviani P. BCR/ABL, mRNA translation and apoptosis. Cell Death Differ 2005;12:534–540.
   PubMed Web of Science ®Google Scholar
• Perrotti D, Calabretta B. Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins. Oncogene 2002;21:8577–8583.
   PubMed Web of Science ®Google Scholar
• Notari M, Neviani P, Santhanam R, . A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood 2006;107:2507–2516.
   Google Scholar
• Evans JR, Mitchell SA, Spriggs KA, . Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 2003;22:8012–8020.
   PubMed Web of Science ®Google Scholar
• Michelotti EF, Michelotti GA, Aronsohn AI, . Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol Cell Biol 1996;16:2350–2360.
   PubMed Web of Science ®Google Scholar
• Gopal V, Kadam P, Preisler H, . Abnormal regulation of the myc gene in myeloid leukemia. Med Oncol Tumor Pharmacother 1992;9:139–147.
   PubMedGoogle Scholar
• Ostareck-Lederer A, Ostareck DH. Control of mRNA translation and stability in haematopoietic cells: the function of hnRNPs K and E1/E2. Biol Cell 2004;96:407–411.
   PubMed Web of Science ®Google Scholar
• Perrotti D, Cesi V, Trotta R, . BCR–ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. Nat Genet 2002;30:48–58.
   PubMed Web of Science ®Google Scholar
• Valencia-Sanchez MA, Liu J, Hannon GJ, . Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006;20:515–524.
   PubMed Web of Science ®Google Scholar
• Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007;23:175–205.
   PubMed Web of Science ®Google Scholar
• Venturini L, Battmer K, Castoldi M, . Expression of the miR-17 - 92 polycistron in chronic myeloid leukemia (CML) CD34 + cells. Blood 2007;109:4399–4405.
   PubMed Web of Science ®Google Scholar
• Agirre X, Jimenez-Velasco A, San Jose-Eneriz E, . Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34 + cells increases USF2-mediated cell growth. Mol Cancer Res 2008;6: 1830–1840.
   PubMed Web of Science ®Google Scholar